4//SEC Filing
Knutson Gregory 4
Accession 0001185185-22-000249
CIK 0001388319other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:01 PM ET
Size
9.1 KB
Accession
0001185185-22-000249
Insider Transaction Report
Form 4
Knutson Gregory
Director
Transactions
- Award
Convertible promissory Note (right to buy)
2022-02-24$100000.00/sh+12,500,000$1,250,000,000,000→ 16,125,000 totalExercise: $0.01From: 2021-02-17Exp: 2024-02-17→ Common Stock (12,500,000 underlying) - Award
Warrant
2022-02-24+12,500,000→ 28,625,000 totalExercise: $0.01From: 2022-02-24Exp: 2023-02-24→ Common Stock (12,500,000 underlying)
Holdings
- 1,675,000
Common Stock
- 38,005,331(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Previously reported; By addendum the conversion price was adjusted and the maturity date extended.
- [F2]Issued in consideration of the extension of the extension of the maturity date.
Documents
Issuer
U.S. Stem Cell, Inc.
CIK 0001388319
Entity typeother
Related Parties
1- filerCIK 0001630138
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:01 PM ET
- Size
- 9.1 KB